Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma
Eur J Cancer
.
2017 Jan:71:117-118.
doi: 10.1016/j.ejca.2016.09.040.
Epub 2016 Dec 8.
Authors
Cheng-Piao Luo
1
,
Han-Yue Mo
2
,
Ling-Ling Wu
3
,
Yun Ma
1
,
Ning-Fu Peng
4
Affiliations
1
Pathology Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, PR China.
2
Surgical Oncology Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, PR China.
3
School of Pharmaceutical, Guangxi Medical University, Nanning, China.
4
Surgical Oncology Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, PR China. Electronic address: pengningfu@163.com.
PMID:
27939845
DOI:
10.1016/j.ejca.2016.09.040
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
B7-H1 Antigen*
Carcinoma, Hepatocellular*
Humans
Liver Neoplasms
Prognosis
Substances
B7-H1 Antigen